Japan’s Kowa says ivermectin has ‘antiviral effect’ against Omicron, other variants
[ad_1] Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado Ruvic TOKYO, Jan 31 (Reuters) – Japanese trading and pharmaceutical company Kowa Co Ltd (7807.T) said on Monday anti-parasite drug ivermectin has an “antiviral effect” against Omicron and other variants of COVID-19 as Phase III clinical […]
Continue Reading